Login / Signup

Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia.

Shun KohsakaSuguru OkamiNaru MoritaToshitaka Yajima
Published in: Journal of clinical medicine (2022)
Treatment cessation/dose reduction of RAASis are common among HF patients. The risks of RAASi/MRA cessation may outweigh the benefits in patients with mild to moderate hyperkalemia.
Keyphrases